Digital Pathology Market to Reach USD 2.12 Billion by 2033 | Rising Adoption of AI and Digital Imaging to Drive Growth - Straits Research

According to a new report by Straits Research, the global digital pathology market size was valued at USD 1.13 billion in 2024 and is projected to grow from USD 1.21 billion in 2025 to USD 2.12 billion by 2033, exhibiting a CAGR of 7.20% during the forecast period (2025-2033).

Digital pathology, the process of converting glass slides into digital slides for computer-based viewing and analysis, has become an essential technology in modern diagnostics. Since the U.S. Food and Drug Administration's 2017 approval of the first whole slide imaging system, the technology has achieved widespread recognition and adoption. The growing prevalence of chronic diseases, aging populations, and the rising need for accurate, cost-effective diagnostic methods are fueling the global market demand.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) : https://straitsresearch.com/report/digital-pathology-market/request-sample

Increasing Cancer Prevalence to Drive Market Growth

The increasing global burden of cancer is one of the major growth drivers of the digital pathology market. According to the World Health Organization (WHO), there were approximately 18.1 million new cancer cases and 9.6 million cancer deaths in 2018. As cancer incidence continues to rise, particularly among the elderly, the need for efficient diagnostic and research tools becomes more urgent. Digital pathology plays a crucial role in drug development and clinical trials by enhancing data accuracy, storage, and integration with electronic health records (EHRs). Furthermore, the growing number of preclinical and clinical trials, driven by the rising focus on drug discovery and personalized medicine, continues to boost market growth.

Technological Advancements Fuel Market Expansion

Rapid technological advancements in digital imaging, computerization, and robotic microscopy are transforming pathology workflows. The introduction of whole slide imaging (WSI) technology offers significant improvements in resolution, speed, and accuracy compared to traditional methods. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms for image analysis enables faster and more precise disease detection. The development of predictive models, hybrid imaging systems, and advanced software platforms is expected to create new opportunities in the global digital pathology landscape.

For more insights and detailed analysis on the Market, visit : https://straitsresearch.com/report/digital-pathology-market/

Regional Insights

North America holds the largest share of the global digital pathology market, led by the United States. Continuous R&D investments, favorable reimbursement policies, and early adoption of digital imaging technologies have propelled regional growth. The increasing use of digital pathology in education, diagnostics, and AI-based research continues to enhance the region's dominance.

In Europe, the market is growing steadily due to government support for digital pathology education and research, along with the rising prevalence of cancer. The United Kingdom and Germany lead regional adoption, supported by initiatives that integrate digital imaging and clinical data for improved cancer diagnosis and treatment.

The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Rising healthcare expenditure, increasing digital adoption, and expanding medical infrastructure in countries like Japan, India, and China are key factors driving regional demand. Japan currently holds the largest share in the region, while India is projected to record the highest CAGR through 2033.

Meanwhile, the LAMEA region (Latin America, Middle East, and Africa) is also expected to experience substantial growth, driven by teleconsultation adoption, rising cancer cases, and supportive government initiatives. However, challenges such as high implementation costs and regulatory complexities remain obstacles to faster adoption.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart) : https://straitsresearch.com/report/digital-pathology-market/request-sample

Market Segmentation

The digital pathology market is segmented by product, type, application, end-user, and region.

By Product: Device, Software, Communication Systems, Storage Systems

By Type: Human Pathology, Veterinary Pathology

By Application: Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education

By End-User: Pharmaceutical & Biotechnology Companies, Hospitals & Reference Laboratories, Academic & Research Institutes

By Region: North America, Europe, Asia-Pacific, Middle East & Africa, Latin America

Among products, devices-including scanners and slide management systems-dominate the market, driven by increased research activity and advancements in whole slide imaging. By application, disease diagnosis is expected to register the fastest growth, fueled by the demand for rapid and accurate testing solutions for chronic diseases.

Key Industry Players

Leica Biosystems
Koninklijke Philips N.V.
Hoffmann-La Roche Ltd
3DHISTECH
Apollo Enterprise Imaging
XIFIN
Huron Digital Pathology
Visiopharm A/S
Corista
Indica Labs
Objective Pathology Services
Sectra AB
OptraSCAN
Glencoe Software
Inspirata, Inc
Mikroscan Technologies
Proscia Inc.
Kanteron Systems

Browse More Insights & Reports :

Tissue Diagnostics Market : https://straitsresearch.com/report/tissue-diagnostics-market

Anatomic Pathology Markethttps://straitsresearch.com/report/anatomic-pathology-market

About Us

For over a decade, Straits Research has been a trusted partner to more than 2,000 small and large enterprises, empowering senior leaders and decision-makers with actionable intelligence to navigate complex markets. Our structured syndicate reports, published year-round, cover critical sectors such as chemicals, materials, food and beverage, healthcare, pharmaceuticals, automotive, technology, aerospace, and defense. Combined with our custom research tailored to client-specific needs, we deliver insights that drive business progress and informed decision-making.

Contact Us

Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.

+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

This release was published on openPR.